Ionis Pharmaceuticals
IONS
IONS
392 hedge funds and large institutions have $9.53B invested in Ionis Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 107 increasing their positions, 127 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.72% less ownership
Funds ownership: 85.59% → 84.87% (-0.72%)
16% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 127
51% less call options, than puts
Call options by funds: $109M | Put options by funds: $223M
Holders
392
Holding in Top 10
10
Calls
$109M
Puts
$223M
Top Buyers
| 1 | +$107M | |
| 2 | +$52.3M | |
| 3 | +$32.3M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$30.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$27.2M |
Top Sellers
| 1 | -$82.5M | |
| 2 | -$71.6M | |
| 3 | -$56.3M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$39.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$24.7M |